Related Experiment Video
Updated: Jun 7, 2026

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Uptake of breast cancer prevention and screening trials
D Gareth Evans1, Michelle Harvie, Nigel Bundred
1Genesis Prevention Centre, University Hospital of South Manchester NHS Trust, Manchester, UK. gareth.evans@cmft.nhs.uk
Background:
Uptake of cancer trials and in particular prevention trials has been disappointing globally.
Methods:
Uptake to three randomised chemotherapy breast cancer prevention trials and two dietary prevention trials in women at increased familial risk were assessed and compared with uptake of screening trials across a range of risk categories.
Results:
Uptake of drug prevention trials remains low at 5.3-13.6%, but is significantly higher in the high (12%) compared to very high risk group (8.4%) for IBIS1 and IBIS2 combined (p=0.004). Recruitment to two dietary prevention studies via mail shot was also disappointingly low at 6.2% and 12.5%. In contrast uptake to two mammography screening trials was >90% in all risk categories.
Conclusions:
More work must be done to improve recruitment to prevention trials if they are to be seen as viable alternatives to risk reducing surgery.
Impact:
Trial designs and decision aids need to be developed to improve recruitment.
Insights
Cancer prevention trial recruitment remains low globally. Improving trial designs and decision aids is crucial for prevention trials to be viable alternatives to surgery.
Area of Science:
- Oncology
- Clinical Trials
- Preventive Medicine
Background:
- Global uptake of cancer prevention trials is notably low.
- This study addresses the disappointing participation rates in cancer prevention research.
Purpose of the Study:
- To assess and compare recruitment rates for different types of cancer prevention trials.
- To evaluate participation in chemotherapy and dietary prevention trials versus screening trials.
Main Methods:
- Uptake data were collected for three randomized chemotherapy breast cancer prevention trials.
- Two dietary prevention trials and screening trials were assessed in women with increased familial risk.
- Comparison of uptake across various risk categories was performed.
Main Results:
- Drug prevention trials showed low uptake (5.3-13.6%), with higher rates in high-risk groups (12%) versus very high-risk groups (8.4%).
- Dietary prevention studies via mail recruitment had low uptake (6.2% and 12.5%).
- Mammography screening trials achieved over 90% uptake across all risk categories.
Conclusions:
- Significant improvements in recruitment for prevention trials are necessary for their viability.
- Development of innovative trial designs and decision aids is essential to boost participation in prevention studies.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Preventive Healthcare Services
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Treatment Resistent Cancers